Journal of Cardiothoracic and Vascular Anesthesia
Volume 17, Issue 1 , Pages 17-21 , February 2003

A case series of low-dose fenoldopam in seventy cardiac surgical patients at increased risk of renal dysfunction

References 

  1. Mora Mangano C, Diamondstone LS, Ramsay JG, et al.  Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med. 1998;128:194–203
  2. Andersson L-G, Ekroth R, Bratteby L-E, et al.  Acute renal failure after coronary surgery. A study of incidence and risk factors in 2009 consecutive patients. Thorac Cardiovasc Surg. 1993;41:237–241
  3. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA. 1996;275:1489–1494
  4. Corwin HL, Sprague SM, DeLaria GA, Norusis MJ. Acute renal failure associated with cardiac operations. A case control study. J Thorac Cardiovasc Surg. 1989;98:1107–1112
  5. Andersson L-G, Bratteby L-E, Ekroth R, et al.  Renal function during cardiopulmonary bypass: Influence of pump flow and systemic blood pressure. Eur J Cardio-thorac Surg. 1994;8:597–602
  6. Lema G, Urzua J, Jalil R, et al.  Renal protection in patients undergoing cardiopulmonary bypass with preoperative abnormal renal function. Anesth Analg. 1998;86:3–8
  7. Ip-Yam PC, Murphy S, Baines M, et al.  Renal function and proteinuria after cardiopulomary bypass: The effects of temperature and mannitol. Anesth Analg. 1994;78:842–847
  8. Valentine S, Barrowcliffe M, Peacock J. A comparison of effects of fixed and tailored cardiopulmonary bypass flowrates on renal function. Anaesth Intens Care. 1993;21:304–308
  9. Lema G, Meneses G, Urzua J, et al.  Effects of extracorporeal circulation on renal function in coronary surgical patients. Anesth Analg. 1995;81:446–451
  10. Stafford Smith M, Conlon PJ, White WD, et al.  Low hematocrit but not perfusion pressure during CPB is predictive for renal failure following CABG surgery. Anesth Analg. 1998;86:SCA102
  11. Canivet JL, Larbuisson R, Damas P, et al.  Plasma renin activity and urine—Beta2-microglobulin during and after cardiopulmonary bypass: pulsatile vs non-pulsatile perfusion. Eur Heart J. 1990;11:1079–1082
  12. Louagie YA, Gonzalez M, Collard E, et al.  Does flow character of cardiopulmonary bypass make a difference?. J Thorac Cardiovasc Surg. 1992;104:1628–1638
  13. Badner NH, Murkin JM, Lok P. Differences in pH management and pulsatile/nonpulsatile perfusion during cardiopulmonary bypass do not influence renal function. Anesth Analg. 1992;75:696–701
  14. Myles PS, Buckland MR, Schenk NJ, et al.  Effect of “renal-dose” dopamine on renal function following cardiac surgery. Anaesth Intens Care. 1993;21:56–61
  15. Davis RF, Lappas DG, Kirklin JK, et al.  Acute oliguria after cardiopulmonary bypass: Renal functional improvement with low-dose dopamine infusion. Crit Care Med. 1982;10:852–856
  16. Hilberman M, Maseda J, Stinson EB, et al.  The diuretic properties of dopamine in patients after open-heart operation. Anesthesiology. 1984;61:489–494
  17. Costa P, Ottino GM, Matani A, et al.  Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction. J Cardiothoracic Anesth. 1990;4:469–473
  18. Kulka P, Tryba M, Zenz M. Preoperative α2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: Results of a randomized, controlled trial. Crit Care Med. 1996;24:947–952
  19. Myles PS, Hunt JO, Holdgaard HO. Clonidine and cardiac surgery: Hemodynamic and metabolic effects, myocardial ischemia and recovery. Anaesth Intensive Care. 1999;27:137–147
  20. Lassnigg A, Donner E, Grubhofer G, et al.  Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol. 2000;11:97–104
  21. Abi-Jaoude F, Brussett A, Ceddaha A, et al.  Clonidine premedication for coronary artery bypass grafting under high-dose alfentanil anesthesia: Intraoperative and postoperative hemodynamic study. J Cardiothoracic Vasc Anesth. 1993;7:35–40
  22. Brogden RN, Markham A. Fenoldopam. A review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies. Drugs. 1997;54:634–650
  23. Elliot WJ, Weber RR, Nelson KS, et al.  Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension. Circulation. 1990;81:970–977
  24. White WB, Halley SE. Comparative effects of intravenous administration of fenoldopam mesylate and sodium nitroprusside in patients with severe hypertension. Arch Intern Med. 1989;149:870–874
  25. Shusterman NH, Elliot WJ, White WB. Fenoldopam but not nitroprusside improves renal function in severely hypertensive patients with impaired renal function. Am J Med. 1993;95:161–168
  26. Poinsot G, Romand J-A, Favre H, Suter PM. Fenoldopam improves renal hemodynamics impaired by positive end-expiratory pressure. Anesthesiology. 1993;79:680–684
  27. Mora Mangano C, Boisvert D, Zhou S, et al. Small reductions in renal function following CABG independently predict prolonged hospitalization Anesth Analg. 2000;90:SCA35
  28. Chiolero R, Borgeat A, Fisher A. Postoperative arrhythmias and risk factors after open heart surgery. Thorac Cardiovasc Surgeon. 1990;39:81–84
  29. Mathew JP, Parks R, Savino JS, et al.  Atrial fibrillation following coronary artery bypass graft surgery. Predictors, outcomes and resource utilization. JAMA. 1996;276:300–306
  30. Ferraris VA, Ferraris SP, Gilliam HS, Berry WR. Predictors of postoperative ventricular dysrhythmias: A multivariate study. J Cardiovasc Surg. 1990;32:12–20
  31. Mathur VS, Swan SK, Lambrecht LJ, et al.  The effects of fenoldopam, a selective dopamine agonist, on systemic and renal hemodynamics in normotensive subjects. Crit Care Med. 1999;27:1832–1837
  32. Allison NL, Dubb JW, Ziemark JA, et al.  The effect of fenoldopam, a dopaminergic agonist, on renal hemodynamics. Clin Pharmacol Ther. 1987;41:228–282

 Address reprint requests to Susan Garwood, MB, ChB, Department of Anesthesiology, Yale University School of Medicine, 333 Cedar Street, PO Box 208051, New Haven, CT 06520-8051. E-mail: susan.garwood@yale.edu

PII: S1053-0770(02)47705-1

doi: 10.1053/jcan.2003.5

Journal of Cardiothoracic and Vascular Anesthesia
Volume 17, Issue 1 , Pages 17-21 , February 2003